文献速递慢性肾脏病

维生素D代谢比值与死亡及CKD进展风险

Vitamin D Metabolic Ratio and Risks of Death and CKD Progression.
PubMed 文献 · Kidney Int Rep · 2019-08-30

基于CRIC队列的病例队列研究,测定入组1年后血清24,25-二羟维生素D3与25-羟维生素D3比值(VDMR),评估其与死亡和进展至终末期肾病(ESRD)的关联。结果显示,较低VDMR与全因死亡风险轻度升高相关(校正肾功能后HR 1.18,95%CI 1.02-1.36),但与ESRD进展无显著关联。

要点

  • 较低VDMR与CKD患者全因死亡风险轻度升高独立相关。
  • 校正eGFR与尿蛋白肌酐比后,VDMR与ESRD进展无显著关联。
  • VDMR作为CYP24A1介导的维生素D清除功能指标,或可用于风险评估。

核心结论

  • 在CKD患者中,较低的VDMR(CYP24A1介导的维生素D清除指标)与全因死亡显著相关,但与进展至ESRD无关。

研究设计与样本

  • CRIC队列病例队列研究,含1080名随机抽取的参与者及发生ESRD或死亡的额外参与者;入组1年后检测血清24,25-二羟维生素D3与25-羟维生素D3,采用逆概率加权分析。

主要发现

  • 平均随访4.9(2.9)年共708例ESRD事件,平均随访6.5(2.5)年共650例死亡事件。
  • 未校正肾功能时,VDMR每降低20 pg/ng与ESRD风险升高相关(HR 1.80,95%CI 1.56-2.08)。
  • 校正肾功能后,VDMR每降低20 pg/ng与ESRD无显著关联(HR 0.94,95%CI 0.81-1.10)。
  • 校正肾功能后,VDMR每降低20 pg/ng与死亡风险轻度升高相关(HR 1.18,95%CI 1.02-1.36)。

临床怎么用

  • 在CKD患者中,VDMR可作为死亡风险分层的潜在功能学指标,但不宜单独用于预测ESRD进展。

局限性

  • VDMR仅在入组1年后单次检测,无法反映动态变化。
  • 为观察性病例队列设计,不能推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Assessment of impaired vitamin D metabolism is limited by lack of functional measures. CYP24A1-mediated vitamin D clearance, calculated as the ratio of serum 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 (the vitamin D metabolic ratio, VDMR), is induced by 1,25-dihydroxyvitamin D and may assess tissue-level activity. We tested associations of the VDMR with risks of death and progression to end-stage renal disease (ESRD) in patients with chronic kidney disease (CKD). METHODS: We studied participants from the Chronic Renal Insufficiency Cohort (CRIC), which included a random subset of 1080 CRIC participants plus additional participants who experienced ESRD or died (case cohort study design). Serum 24,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 was measured 1 year after enrollment. The primary outcomes included death and progression to ESRD. Using inverse probability weighting, we tested associations of VDMR (24,25[OH]2D3/25[OH]D3) with risks of death and ESRD, adjusting for demographics, comorbidity, and kidney function (estimated glomerular filtration rate [eGFR] and urine protein-to-creatinine ratio [PCR]). RESULTS: There were a total of 708 ESRD events and 650 deaths events over mean (SD) follow-up periods of 4.9 (2.9) years and 6.5 (2.5) years, respectively. Lower VDMR was associated with increased risk of ESRD prior to adjusting for kidney function (hazard ratio [HR], 1.80 per 20 pg/ng lower VDMR; 95% confidence interval [CI], 1.56-2.08), but not with adjustment for kidney function (HR, 0.94 per 20 pg/ng; 95% CI, 0.81-1.10). Lower VDMR was associated with modestly increased mortality risk, including adjustment for kidney function (HR, 1.18 per 20 pg/ng; 95% CI, 1.02-1.36). CONCLUSION: Lower VDMR, a measure of CYP24A1-mediated vitamin D clearance, was significantly associated with all-cause mortality but not with progression to ESRD in patients with CKD.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Bansal N, Katz R, Appel L, et al. Vitamin D Metabolic Ratio and Risks of Death and CKD Progression. Kidney Int Rep. 2019. PMID: 31891001. doi:10.1016/j.ekir.2019.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。